Covance Clinical-Biotech, formerly known as Chiltern International Limited, is a leading provider of clinical and contract research services for the bio-pharmaceutical and medical device industries. The company offers a wide range of services, including early phase, global clinical development, late phase, bio-metrics, medical and regulatory affairs services, as well as resourcing services. With expanded solutions for biotechs, Covance Clinical-Biotech provides tailored clinical trial solutions designed around the needs of biotech ventures. Learn more at https://www.covance.com/covance-chiltern.html.